Kyvsgaard ER, Fuglkjaer AD, Al-Mashhadi AL, Hasselbalch Riley C, et al. A real-world comparison of CD20xCD3 bispecific antibodies versus chemotherapy regimens in 3+ line relapsed/refractory diffuse large B cell lymphoma. Leuk Lymphoma 2026 Mar 11:1-5. doi: 10.1080/10428194.2026.2637858.
PMID: 41811794